Chuan Li

Chemokine receptors and their interactors in HIV-1 replication: potential therapeutic targets

D. Dupré, Yi-Qun Kuang, Chuan Li, 2015 .

The Block-and-Lock Strategy for Human Immunodeficiency Virus Cure: Lessons Learned from Didehydro-Cortistatin A.

S. Valente, Chuan Li, L. Mori, 2021, The Journal of infectious diseases.

Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat

S. Valente, G. Mousseau, Chuan Li, 2019, Epigenetics & Chromatin.

The XPB Subunit of the TFIIH Complex Plays a Critical Role in HIV-1 Transcription, and XPB Inhibition by Spironolactone Prevents HIV-1 Reactivation from Latency

B. Lacombe, M. Cameron, M. Pipkin, 2020, Journal of Virology.

The Tat inhibitor didehydro‐cortistatin A suppresses SIV replication and reactivation

Ian Mitchelle S. de Vera, D. Kojetin, Suzie Thenin-Houssier, 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a "Block-and-Lock" Strategy for HIV-1 Treatment.

M. Fallahi, L. Trautmann, J. Garcia, 2017, Cell reports.

The chaperone protein p32 stabilizes HIV-1 Tat and strengthens the p-TEFb/RNAPII/TAR complex promoting HIV transcription elongation

M. Pipkin, S. Valente, Adam J. Getzler, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Tat inhibition by didehydro-Cortistatin A promotes heterochromatin formation at the HIV-1 long terminal repeat

S. Valente, G. Mousseau, Chuan Li, 2019, Epigenetics & Chromatin.

The chaperone protein p32 stabilizes HIV-1 Tat and strengthens the p-TEFb/RNAPII/TAR complex promoting HIV transcription elongation

M. Pipkin, S. Valente, Adam J. Getzler, 2022, Proceedings of the National Academy of Sciences of the United States of America.